At its meeting on 29 August 2022 the Transparency Council adopted opinion No. 132/2022 on the active substances entecavirum and tenofovirum disoproxilum for off-label indications.
Publication with the minutes of the Transparency Council meeting
At its meeting on 29 August 2022 the Transparency Council adopted opinion No. 132/2022 on the active substances entecavirum and tenofovirum disoproxilum for off-label indications.
Publication with the minutes of the Transparency Council meeting